Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kluth

Showing results (611-620 of 1,145) with videos related to

Pageof 115
Sort By:
Plos One|August 1, 2015
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate CancerNathaniel Melling, Levon Harutyunyan, Claudia Hube-Magg, et al.
Endocrine Pathology|March 8, 2020
Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine CarcinomasChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Urologic Oncology|July 11, 2022
Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy coreBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
European Urology Focus|July 21, 2017
The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysisIlaria Lucca, Patrice Jichlinski, Shahrokh F Shariat, et al.
Oncology Reports|July 3, 2015
Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletionKatharina Grupp, Laura Roettger, Martina Kluth, et al.
The Prostate|October 18, 2021
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patientsBenedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, et al.
International Urology and Nephrology|November 16, 2021
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patientsBenedikt Hoeh, Jan L Hohenhorst, Rocco Flammia, et al.
Prostate Cancer and Prostatic Diseases|September 4, 2013
Impact of statin use on biochemical recurrence in patients treated with radical prostatectomyM Rieken, L A Kluth, E Xylinas, et al.
Der Urologe. Ausg. A|July 4, 2020
[Movember health care initiative 2019: prostate cancer screening at the University Hospital Frankfurt]M Wenzel, C Humke, S Wicker, et al.
Diagnostics (Basel, Switzerland)|May 13, 2023
External Tertiary-Care-Hospital Validation of the Epidemiological SEER-Based Nomogram Predicting Downgrading in High-Risk Prostate Cancer Patients Treated with Radical ProstatectomyCristina Cano Garcia, Mike Wenzel, Mattia Luca Piccinelli, et al.
Pageof 115

Showing results (611-620 of 1,145) with videos related to

Sort By:
Pageof 115
Plos One|August 1, 2015
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate CancerNathaniel Melling, Levon Harutyunyan, Claudia Hube-Magg, et al.
Endocrine Pathology|March 8, 2020
Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine CarcinomasChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Urologic Oncology|July 11, 2022
Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy coreBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
European Urology Focus|July 21, 2017
The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysisIlaria Lucca, Patrice Jichlinski, Shahrokh F Shariat, et al.
Oncology Reports|July 3, 2015
Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletionKatharina Grupp, Laura Roettger, Martina Kluth, et al.
The Prostate|October 18, 2021
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patientsBenedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, et al.
International Urology and Nephrology|November 16, 2021
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patientsBenedikt Hoeh, Jan L Hohenhorst, Rocco Flammia, et al.
Prostate Cancer and Prostatic Diseases|September 4, 2013
Impact of statin use on biochemical recurrence in patients treated with radical prostatectomyM Rieken, L A Kluth, E Xylinas, et al.
Der Urologe. Ausg. A|July 4, 2020
[Movember health care initiative 2019: prostate cancer screening at the University Hospital Frankfurt]M Wenzel, C Humke, S Wicker, et al.
Diagnostics (Basel, Switzerland)|May 13, 2023
External Tertiary-Care-Hospital Validation of the Epidemiological SEER-Based Nomogram Predicting Downgrading in High-Risk Prostate Cancer Patients Treated with Radical ProstatectomyCristina Cano Garcia, Mike Wenzel, Mattia Luca Piccinelli, et al.
Pageof 115